Cerner (NASDAQ:CERN) Stock Rating Upgraded by BidaskClub

BidaskClub upgraded shares of Cerner (NASDAQ:CERN) from a hold rating to a buy rating in a research report report published on Friday morning, BidAskClub reports.

Several other analysts also recently weighed in on the company. Canaccord Genuity lowered their target price on Foot Locker from $82.00 to $81.00 and set a buy rating for the company in a research note on Friday, May 24th. Zacks Investment Research downgraded Wix.Com from a hold rating to a sell rating in a research note on Monday, April 8th. Morgan Stanley set a $165.00 target price on Caterpillar and gave the company a buy rating in a research note on Wednesday, April 10th. Robert W. Baird lifted their price target on Cerner from $67.00 to $71.00 and gave the stock an outperform rating in a research note on Wednesday, April 10th. Finally, ValuEngine downgraded Zosano Pharma from a buy rating to a hold rating in a research note on Wednesday, May 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eleven have assigned a buy rating to the stock. The company presently has a consensus rating of Buy and an average target price of $70.00.

Shares of Cerner stock opened at $75.83 on Friday. The firm’s 50-day simple moving average is $72.66. The company has a quick ratio of 2.55, a current ratio of 2.58 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of $24.80 billion, a P/E ratio of 34.31, a PEG ratio of 2.32 and a beta of 0.89. Cerner has a 1-year low of $48.78 and a 1-year high of $76.47.

Cerner (NASDAQ:CERN) last announced its earnings results on Thursday, April 25th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.06. The company had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.39 billion. Cerner had a return on equity of 14.86% and a net margin of 11.65%. The company’s revenue was up 7.5% on a year-over-year basis. During the same period last year, the firm earned $0.58 earnings per share. As a group, sell-side analysts expect that Cerner will post 2.44 earnings per share for the current year.

The company also recently declared a special dividend, which will be paid on Friday, July 26th. Investors of record on Tuesday, June 18th will be paid a $0.18 dividend. The ex-dividend date is Monday, June 17th. Cerner’s dividend payout ratio (DPR) is 32.58%.

In related news, Director R Halsey Wise bought 7,600 shares of the firm’s stock in a transaction on Tuesday, April 30th. The stock was bought at an average cost of $65.76 per share, for a total transaction of $499,776.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Randy D. Sims sold 40,000 shares of Cerner stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $72.45, for a total value of $2,898,000.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 441,468 shares of company stock valued at $30,777,997. 4.71% of the stock is currently owned by insiders.

A number of hedge funds have recently modified their holdings of CERN. Country Club Trust Company n.a. raised its holdings in shares of Cerner by 24.7% during the second quarter. Country Club Trust Company n.a. now owns 12,013 shares of the company’s stock valued at $881,000 after buying an additional 2,383 shares during the last quarter. Capital Investment Services of America Inc. raised its holdings in shares of Cerner by 0.6% during the second quarter. Capital Investment Services of America Inc. now owns 227,501 shares of the company’s stock valued at $16,676,000 after buying an additional 1,465 shares during the last quarter. NN Investment Partners Holdings N.V. raised its holdings in shares of Cerner by 33.8% during the second quarter. NN Investment Partners Holdings N.V. now owns 38,158 shares of the company’s stock valued at $2,797,000 after buying an additional 9,636 shares during the last quarter. Xact Kapitalforvaltning AB raised its holdings in shares of Cerner by 5.0% during the second quarter. Xact Kapitalforvaltning AB now owns 53,930 shares of the company’s stock valued at $3,953,000 after buying an additional 2,551 shares during the last quarter. Finally, Acropolis Investment Management LLC raised its holdings in shares of Cerner by 2.0% during the second quarter. Acropolis Investment Management LLC now owns 7,494 shares of the company’s stock valued at $549,000 after buying an additional 148 shares during the last quarter. Institutional investors own 81.62% of the company’s stock.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Story: How to Invest in Growth Stocks

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.